TITAN PHARMACEUTICALS INC DE's ticker is TTNP and the CUSIP is 888314606. A total of 2 filers reported holding TITAN PHARMACEUTICALS INC DE in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $746 | -26.6% | 1,573 | 0.0% | 0.00% | – |
| Q2 2023 | $1,016 | +101500.0% | 1,573 | -2.4% | 0.00% | – |
| Q1 2023 | $1 | 0.0% | 1,612 | 0.0% | 0.00% | – |
| Q4 2022 | $1 | -100.0% | 1,612 | -83.9% | 0.00% | – |
| Q1 2022 | $10,000 | – | 10,041 | +9462.9% | 0.00% | – |
| Q4 2021 | $0 | -100.0% | 105 | -90.7% | 0.00% | – |
| Q3 2021 | $2,000 | – | 1,134 | +608.8% | 0.00% | – |
| Q2 2021 | $0 | -100.0% | 160 | -97.7% | 0.00% | – |
| Q1 2021 | $20,000 | -23.1% | 6,821 | -14.4% | 0.00% | -100.0% |
| Q4 2020 | $26,000 | – | 7,972 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Virtu Financial LLC | 20,080 | $16 | 0.00% |
| TRUIST FINANCIAL CORP | 625,089 | $489,507 | 0.00% |
| Level Financial Advisors | 987 | $1,000 | 0.00% |
| Westside Investment Management, Inc. | 4 | $0 | 0.00% |
| Global Wealth Strategies & Associates | 40 | $31 | 0.00% |
| JPMORGAN CHASE & CO | 61 | $0 | 0.00% |
| Renaissance Technologies | 134,410 | $105 | 0.00% |
| VANGUARD GROUP INC | 82,051 | $64,254 | 0.00% |
| UBS Group AG | 165 | $129 | 0.00% |
| IFP Advisors, Inc | 14 | $1 | 0.00% |